SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
74.80    0.00 (0.00%)
Bid:
74.00
Ask:
100.00
Spread: 26.00 (35.135%)
Market Cap: £2.60b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

Share Buyback Programme

26 Apr 2022 15:52

RNS Number : 4189J
Taylor Wimpey PLC
26 April 2022
 

 

 

 

 

 

 

 

 

26 April 2022

Taylor Wimpey plc

Share Buyback Programme - Launch of Second Tranche

 

Taylor Wimpey plc (the "Company") announces that it has instructed Credit Suisse International ("CSI") to purchase up to £75,000,000 of the Company's shares as part of the second tranche (the "Second Tranche") of its £150,000,000 share buyback programme announced on 3 March 2022 (the "Buyback Programme"). CSI will act as principal for the simultaneous on-sale of such shares to the Company and will make its trading decisions concerning the timing of the purchases of the Company's ordinary shares independently of the Company. Purchases of the Company's shares under the Second Tranche will commence tomorrow, 27 April 2022, and end no later than 29 July 2022.

 

The purpose of the Buyback Programme is to return excess capital to the Company's shareholders and reduce the share capital of the Company, and it is expected that the implementation of the Buyback Programme will enhance earnings per share.

 

To the extent permitted by law, ordinary shares purchased under the Buyback Programme will be cancelled.

 

Any acquisitions under the Second Tranche will be carried out within certain pre-set parameters in accordance with the Company's general authority to repurchase shares as granted at the Company's 2022 Annual General Meeting, which took place earlier today, pursuant to which the maximum number of shares to be bought back by the Company may not exceed 364,892,070 ordinary shares of 1 pence each.

 

Any acquisitions will be made in accordance with the EU Market Abuse Regulation (596/2014) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and Chapter 12 of the Listing Rules.

 

 

-Ends-

 

 

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 858323

Chris Carney, Group Finance Director

Alice Black, Group General Counsel and Company Secretary

 

Notes to editors:

Taylor Wimpey plc is a customer-focused homebuilder operating at a local level from 23 regional businesses across the UK. We also have operations in Spain. Our purpose is to deliver great homes and create thriving communities.

For further information please visit the Group's website: www.taylorwimpey.co.uk/corporate

Follow us on Twitter @TaylorWimpeyplc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSIFMITMTATBBT
Date   Source Headline
12th Jun 20267:00 amRNSDirector/PDMR Shareholding
9th Jun 20263:11 pmRNSDirector/PDMR Shareholding
9th Jun 20267:00 amRNSDirectorate change
1st Jun 20267:00 amRNSTotal Voting Rights
20th May 202610:41 amRNSHolding(s) in Company
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20269:49 amRNSDirector/PDMR Shareholding
15th May 20261:32 pmRNSHolding(s) in Company
14th May 20267:00 amRNSTransaction in Own Shares
11th May 20264:10 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20263:30 pmRNSHolding(s) in Company
6th May 202611:05 amRNSHolding(s) in Company
5th May 202611:28 amRNSHolding(s) in Company
1st May 202611:53 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20264:34 pmRNSDirector/PDMR Shareholding
28th Apr 20264:23 pmRNSResult of AGM
28th Apr 20267:00 amRNSTrading Statement
23rd Apr 20269:25 amRNSTransaction in Own Shares
20th Apr 20268:41 amRNSDirector Declaration
16th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20263:42 pmRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20261:36 pmRNSTotal Voting Rights
30th Mar 20262:19 pmRNSHolding(s) in Company
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20263:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20262:22 pmRNSHolding(s) in Company
20th Mar 20263:37 pmRNSAnnual Financial Report and Notice of Meeting
19th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20263:23 pmRNSDirector/PDMR Shareholding
10th Mar 20263:23 pmRNSDirector/PDMR Shareholding
6th Mar 202611:44 amRNSDirector/PDMR Shareholding
5th Mar 20267:01 amRNSShare Buyback Programme
5th Mar 20267:00 amRNSTAYLOR WIMPEY PLC FULL YEAR RESULTS
2nd Mar 202611:50 amRNSTotal Voting Rights
10th Feb 20263:19 pmRNSDirector/PDMR Shareholding
2nd Feb 20262:17 pmRNSTotal Voting Rights
22nd Jan 20263:11 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSTrading Statement
9th Jan 20262:51 pmRNSDirector/PDMR Shareholding
2nd Jan 202612:02 pmRNSTotal Voting Rights
2nd Jan 202611:59 amRNSBlock listing Interim Review
2nd Jan 202611:54 amRNSBlock listing Interim Review
15th Dec 20254:17 pmRNSDirector/PDMR Shareholding
9th Dec 20254:21 pmRNSDirector/PDMR Shareholding
9th Dec 20254:18 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.